Descriptor
| Behavior Disorders | 2 |
| Check Lists | 2 |
| Intelligence | 2 |
| Measures (Individuals) | 2 |
| Outcomes of Treatment | 2 |
| Rating Scales | 2 |
| Adolescents | 1 |
| Behavior Problems | 1 |
| Body Weight | 1 |
| Child Behavior | 1 |
| Drug Therapy | 1 |
| More ▼ | |
Author
| Croonenberghs, Jan | 1 |
| Fegert, Joerg M. | 1 |
| Findling, Robert L. | 1 |
| Handen, Benjamin L. | 1 |
| Hardan, Antonio Y. | 1 |
| de Smedt, Goedele | 1 |
| van Dongen, Stefan | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
What Works Clearinghouse Rating
Peer reviewedCroonenberghs, Jan; Fegert, Joerg M.; Findling, Robert L.; de Smedt, Goedele; van Dongen, Stefan – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
Objective: To determine the long-term safety and effectiveness of risperidone for severe disruptive behaviors in children. Method: A multisite, 1-year, open-label study of patients aged 5 to 14 years with disruptive behaviors and subaverage intelligence was conducted. Results: Seventy-three percent of the 504 patients enrolled completed the study.…
Descriptors: Social Behavior, Psychiatry, Pharmacology, Child Behavior
Direct linkHanden, Benjamin L.; Hardan, Antonio Y. – Journal of the American Academy of Child & Adolescent Psychiatry, 2006
Objective: Olanzapine, an atypical antipsychotic, has been shown to be efficacious for treatment of psychotic and mood disorders in adults. This prospective, open-label study was conducted to examine the safety and usefulness of olanzapine in treating disruptive behavior disorders in adolescents with subaverage intelligence. Method: Sixteen…
Descriptors: Check Lists, Intelligence, Safety, Moderate Mental Retardation
